DeForest N, Kavitha B, Hu S, Isaac R, Krohn L, Wang M, Du X, Saldanha CDA, Gylys J, Merli E, Abagyan R, Najmi L, Mohan V, Alnylam Human Genetics, AMP-T2D Consortium, Flannick, J, Peloso GM, Gordts P, Heinz S, Deaton AM, Khera AV, Olefsky J, Radha V, Majithia, AR. Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteins. 2023, Cell Genomics 3, 100339July 12, 2023. DOI
Trieger G, Pessentheiner A, Purcell S, Green C, DeForest N, Willert K, Majithia A, Metallo C, Godula K, Gordts P. Glycocalyx engineering with heparan sulfate mimetics attenuates Wnt activity during adipogenesis to promote glucose uptake and metabolism. J. Biol. Chem. (2023) 299(5) 104611. DOI
Isaac R, Vinik Y, Mikl M, Shatz-Azoulay H, Yaakobi A, DeForest N, Majithia A, Webster N, Elhanany E, Zick Y. A Seven-Transmembrane Protein -TM7SF3, Resides in Nuclear Speckles and Regulates Alternative Splicing. Accepted iScience 2022.
Boeder S, Kobayashi E, Ramesh G, Serences B, Kulasa K, Majithia, AR. Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: a Retrospective Study. Journal of Diabetes Science and Technology. 2022;0(0). DOI DeForest N, Majithia, AR. Genetics of Type 2 Diabetes: Implications from Large-Scale Studies. Curr Diab Rep 22, 227–235 (2022). DOI
Majithia AR, Erani DM, Kusiak CM, et al. Medication Optimization Among People With Type 2 Diabetes Participating in a CGM-Driven Virtual Care Program: Prospective Trial. JMIR Formative Research. 2022 Feb. DOI
Du X, DeForest N, Majithia AR. Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities. Frontiers in Endocrinology. 2021 Dec;12:1500. DOI
Bergenstal RM, Layne JE, Zisser H, Gabbay RA, Barleen NA, Lee AA, Majithia AR, Parkin CG, Dixon RF. Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic. Diabetes Technol Ther. 2021 Feb;23(2):128-132. DOI
Majithia AR, Kusiak CM, Armento Lee A, Colangelo FR, Romanelli RJ, Robertson S, Miller DP, Erani DM, Layne JE, Dixon RF, Zisser H. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor–Driven Virtual Diabetes Clinic: Prospective Trial. J Med Internet Res 2020;22(8):e21778. DOI
Dixon RF, Zisser H, Layne JE, et al. A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits. J Diabetes Sci Technol. 2020;14(5):908-911. DOI
Jia T, Munson B, Lango Allen H, Ideker T, Majithia AR. Thousands of missing variants in the UK Biobank are recoverable by genome realignment. Ann Hum Genet. 2020 Mar; 84: 214– 220. DOI
Lal D, May P, Perez-Palma E, Samocha KE, Kosmicki JA, Robinson EB, Møller RS, Krause R, Nürnberg P, Weckhuysen S, De Jonghe P, Guerrini R, Niestroj LM, Du J, Marini C; EuroEPINOMICS-RES Consortium, Ware JS, Kurki M, Gormley P, Tang S, Wu S, Biskup S, Poduri A, Neubauer BA, Koeleman BPC, Helbig KL, Weber YG, Helbig I, Majithia AR, Palotie A, Daly MJ. Gene family information facilitates variant interpretation and identification of disease-associated genes in neurodevelopmental disorders. Genome Med 12, 28 (2020). DOI
Majithia AR*, Wiltschko AB, Zheng H, Walford GA, Nathan DM. Rate of change of pre-meal glucose measured by continuous glucose monitoring predicts post-meal glycemic excursions in patients with type 1 diabetes: Implications for therapy. Journal of Diabetes Science and Technology. Journal of Diabetes Science and Technology. 2018 PMID: 28868899 *corresponding author
Agostini M, Schoenmakers E, Beig J, Fairall L, Szatmari I, Rajanayagam O, Muskett FW, Adams C, Marais AD, O'Rahilly S, Semple RK, Nagy L, Majithia AR, Schwabe JWR, Blom DJ, Murphy R, Chatterjee K, Savage DB. A Pharmacogenetic Approach to the Treatment of Patients With PPARG Mutations. Diabetes. 2018 Jun;67(6):1086-1092. PMCID: PMC5967605